![Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.]()
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.Misset, J L; di Palma, M; Delgado, M; Plagne, R; Chollet, P; Fumoleau, P; Le Mevel, B; Belpomme, D; Guerrin, J; Fargeot, P; Metz, R; Ithzaki, M; Hill, C; Mathé, G · Journal of Clinical Oncology · 1996